The Effectiveness of Positive Psychotherapy on ICAM and VCAM in Ischemic Heart Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181228042155N4

Enrollment

Registered

2020-10-25

Start date

2019-04-17

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stable Angina. Angina pectoris

Interventions

Intervention 1: Intervention group: intervention group received an eight-session intervention (utilizing 17 positive psychological exercises) provided via two-hour weekly in-person group sessions. The

Eligibility

Sex/Gender

All

Age

40 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with confirmed diagnosis of stable angina significant stenosis more than 70% in at least one the coronary arteries chronic coronary syndrome no evidence or history of autoimmune or acute inflammatory disease or consumption of immunologic drugs no evidence or history of psychosis or consumption of psychological drugs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
ICAM concentration. Timepoint: At the beginning of the study (before the intervention) and immediately after the training and 4 weeks after the course. Method of measurement: ICAM concentration measured using ELISA kit.;VCAM concentration. Timepoint: At the beginning of the study (before the intervention) and immediately after the training and 4 weeks after the course. Method of measurement: VCAM concentration measured using ELISA kit.;Quality of Life (EQ-5D). Timepoint: At the beginning of the study (before the intervention) and immediately after the training and 4 weeks after the course. Method of measurement: Quality of life is measured using a questionnaire (EQ-5D (EuroQol-5D).	—

Measure

Time frame

ICAM concentration. Timepoint: At the beginning of the study (before the intervention) and immediately after the training and 4 weeks after the course. Method of measurement: ICAM concentration measured using ELISA kit.;VCAM concentration. Timepoint: At the beginning of the study (before the intervention) and immediately after the training and 4 weeks after the course. Method of measurement: VCAM concentration measured using ELISA kit.;Quality of Life (EQ-5D). Timepoint: At the beginning of the study (before the intervention) and immediately after the training and 4 weeks after the course. Method of measurement: Quality of life is measured using a questionnaire (EQ-5D (EuroQol-5D).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoume Sadeghi

Esfahan University of Medical Sciences

sadeghimasoumeh@gmail.com+98 31 3611 5208

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026